View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
THURSDAY, Nov. 4 (HealthDay News) -- The presence of microalbuminuria is an additional marker that can identify a high-risk subset of patients without diabetes who have the metabolic syndrome, according to research published in the Oct. 1 issue of the American Journal of Cardiology.
Luis Afonso, M.D., of Wayne State University in Detroit, and colleagues conducted a post hoc analysis of 5,809 individuals without diabetes from the Multiethnic Study of Atherosclerosis. The participants were divided into four groups on the basis of the presence or absence of metabolic syndrome and microalbuminuria.
Compared with the other groups, the group of participants having both metabolic syndrome and microalbuminuria had a consistently stronger association with markers of systemic inflammation, subclinical atherosclerosis, and most cardiovascular end points. The authors concluded that stratification by the presence of microalbuminuria can help identify a high-risk group of individuals without diabetes within the population of those with the metabolic syndrome.
"A possibility always exists of unmeasured confounders and residual confounding affecting the study results. Such issues are inherent limitations of observational cohort studies," the authors write. "Nevertheless, microalbuminuria represents a simple, but useful, clinical tool that might help identify a high-risk subgroup of non-diabetic persons with the metabolic syndrome."
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top